PMID: 2501522Jul 1, 1989Paper

Extended indications for placement of an inferior vena cava filter

Journal of Vascular Surgery
M J RohrerB S Cutler

Abstract

To study the morbidity and mortality rates after placement of an inferior vena cava filter and to define the appropriate indications for interruption of the inferior vena cava, the records of all patients who underwent insertion of a Greenfield filter during the decade January 1978 to December 1987 were reviewed. Patients were designated as having either a traditional or extended indication for placement of an inferior vena cava filter. Two hundred sixty inferior vena cava filters were placed in 264 attempts, with no deaths related to insertion of the filter. An extended indication was the primary reason for placement of the Greenfield filter in 66 (25%) of the patients. In patients with extended indications there were no cases of air embolism or filter misplacement and only three wound complications (4.5%). Pulmonary embolism after insertion of the inferior vena cava filter occurred in three patients (4.5%), with one fatality (1.5%). Inferior vena cava occlusion was documented in three cases (4.5%), and manifestations of the postphlebitic syndrome in early follow-up were present in two patients (3.0%). As the procedures to prevent fatal pulmonary embolism have become safer, more efficacious, and less morbid, the number of pati...Continue Reading

References

Jan 1, 1976·Drugs·D A Tibbutt, C N Chesterman
Apr 1, 1977·The Journal of Trauma·B B BrachR Convery
May 1, 1976·Klinichna khirurhiia·M F Mazurik, I I Kulik
Mar 19, 1966·Lancet·R J Kernohan, C Todd
May 1, 1973·The Journal of Trauma·W D FullenJ J McDonough
Oct 1, 1974·Annals of Surgery·L J GreenfieldR C Elkins
Nov 1, 1973·Archives of Surgery·S M Lindenauer
May 1, 1971·Archives of Surgery·C H Fuller, O L Willbanks
Oct 1, 1969·Annals of Surgery·W W CoonM J Symons
Mar 1, 1982·Diseases of the Colon and Rectum·R E KusminskyJ P Boland

❮ Previous
Next ❯

Citations

May 1, 1994·Journal of Vascular and Interventional Radiology : JVIR·M P RosenD Kim
Sep 1, 1995·Annals of Vascular Surgery·D B WalshJ A Baron
Nov 1, 1995·Annals of Vascular Surgery·J O DefraigneR Limet
Aug 1, 1994·American Journal of Surgery·J J AlexanderJ J Piotrowski
Nov 5, 1999·Journal of Vascular Surgery·J BlebeaR G Atnip
Nov 1, 1996·Journal of Vascular Surgery·M A AswadW R Flinn
Sep 8, 1999·Journal of Vascular Surgery·UNKNOWN Vena Caval Filter Consensus Conference
Feb 2, 1999·American Journal of Surgery·J H ThomasS J Rosenthal
Aug 17, 2005·The American Journal of the Medical Sciences·Paul J FaillaGeorge H Karam
Feb 7, 2001·Chest·P MonagleM Andrew
Aug 20, 2002·AJR. American Journal of Roentgenology·Michael A SavinRonald E Olson
Jul 1, 1997·The Orthopedic Clinics of North America·K D MontgomeryD L Helfet
Oct 31, 2006·Injury·Peter V GiannoudisJai V Patel
Dec 14, 2004·Vascular and Endovascular Surgery·Enrico AscherS Salles-Cunha
Feb 1, 2011·Vascular and Endovascular Surgery·Rafael D MalgorNicos Labropoulos
Jan 30, 2007·Journal of Intensive Care Medicine·Frederick RogersRonald F Sing
Jun 11, 2004·Journal of Intensive Care Medicine·Michael B Streiff
Aug 1, 1997·The Journal of Trauma·T E QuirkeK G Swan
Nov 1, 1995·Journal of Endovascular Surgery : the Official Journal of the International Society for Endovascular Surgery·H A al Zahrani
Jul 31, 2004·The Journal of Trauma·Christopher S MorrisSteven R Shackford
Jun 3, 1999·The Australian and New Zealand Journal of Surgery·P T ChinM S Stephen
Jun 11, 2008·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Erin H MurphyFrank R Arko

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.